What is the clinical significance of a D-dimer level of 392 ng/mL (fibrinogen‑equivalent units) when assessing for venous thromboembolism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

D-dimer of 392 ng/mL: Clinical Significance

A D-dimer of 392 ng/mL is below the standard threshold of 500 ng/mL and effectively rules out venous thromboembolism (VTE) in patients with low or intermediate pre-test probability, eliminating the need for further imaging. 1

Interpretation Framework

The clinical utility of this D-dimer result depends entirely on your pre-test probability assessment:

Low Pre-Test Probability (≤10%)

  • Stop here—VTE is excluded. No further testing or anticoagulation is needed 1
  • The negative predictive value approaches 97-100% in this population 2, 3
  • This applies to both deep vein thrombosis (DVT) and pulmonary embolism (PE)

Intermediate Pre-Test Probability (~15-25%)

  • VTE is effectively ruled out with this negative D-dimer 1
  • Guidelines support using D-dimer as the initial strategy in this population, with imaging reserved only for positive results
  • Your patient can be safely managed without ultrasound or CT imaging

High Pre-Test Probability (≥50%)

  • Proceed directly to imaging regardless of D-dimer result 1
  • D-dimer should not be used as a screening tool in high-probability patients
  • Order CT pulmonary angiography (CTPA) for suspected PE or compression ultrasound for suspected DVT

Critical Caveats

D-dimer loses reliability in specific populations:

  • Hospitalized patients (high false-positive rate with standard thresholds) 1
  • Post-surgical patients
  • Pregnant patients
  • Patients already on anticoagulation 1

In these groups, even a negative D-dimer cannot safely exclude VTE—proceed directly to imaging if clinical suspicion exists.

Age-Adjusted Consideration

For outpatients over age 50, consider using an age-adjusted cutoff: age (years) × 10 ng/mL 1. This increases specificity without compromising safety. However, at 392 ng/mL, your result would be negative even for patients up to age 49 using standard thresholds.

Special Clinical Scenarios

The YEARS algorithm offers an alternative approach 4:

  • If the patient has no clinical items (signs of DVT, hemoptysis, or PE as most likely diagnosis): VTE excluded if D-dimer <1000 ng/mL
  • If one or more clinical items present: VTE excluded if D-dimer <500 ng/mL
  • Your result of 392 ng/mL satisfies both criteria

Rare Exception: VTE with Low D-dimer

While uncommon, VTE can occur with D-dimer <500 ng/mL in approximately 2-13% of cases 5. These patients tend to be:

  • Younger
  • Have lower thrombotic burden
  • Present with milder symptoms
  • Have higher rates of thrombophilia or family history of VTE

If clinical suspicion remains very high despite negative D-dimer, do not rely on the D-dimer alone—proceed to imaging. This is particularly important if the patient has known thrombophilia or strong family history.

Assay-Specific Requirements

Ensure a highly sensitive D-dimer assay was used (such as ELISA method) 1, 2. Less sensitive latex agglutination tests have insufficient negative predictive value (sensitivity only 87% vs. 98% for ELISA) and should not be used to exclude VTE 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.